Feprosidnine
Feprosidnine is a stimulant drug that was developed in the Soviet Union in the 1970s. It is chemically related to the drug prosidnine and has been used for its nootropic and psychostimulant effects.
Chemical Structure and Properties[edit]
Feprosidnine is a derivative of prosidnine, with the chemical structure of 2-(2-furyl)-2-phenyl-2-(1-pyrrolidinyl)ethanol. It is a member of the pyrrolidine class of compounds, which are known for their stimulating effects on the central nervous system.
Pharmacology[edit]
Feprosidnine acts primarily as a dopamine reuptake inhibitor, which increases the levels of dopamine in the brain. This action is similar to that of other stimulant drugs such as methylphenidate and amphetamine. The increased dopamine levels are associated with enhanced cognitive function, improved memory, and increased alertness.
Medical Uses[edit]
Feprosidnine has been used in the treatment of various conditions, including attention deficit hyperactivity disorder (ADHD), narcolepsy, and certain types of depression. Its nootropic effects have also made it a subject of interest for enhancing cognitive performance in healthy individuals.
Side Effects[edit]
Common side effects of feprosidnine include insomnia, anxiety, headache, and nausea. In some cases, it may also cause tachycardia and hypertension. Long-term use can lead to tolerance, dependence, and addiction.
Legal Status[edit]
The legal status of feprosidnine varies by country. In some regions, it is classified as a controlled substance due to its potential for abuse and addiction. In others, it may be available by prescription for specific medical conditions.
Research[edit]
Research on feprosidnine has primarily focused on its potential as a cognitive enhancer and its effects on the central nervous system. Studies have shown that it can improve learning and memory in animal models, but more research is needed to fully understand its effects in humans.
See Also[edit]
References[edit]
External Links[edit]
-
 | This medical article is a stub. You can help Wikipedia by adding missing information. |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
